Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza.

Sui B, Bamba D, Weng K, Ung H, Chang S, Van Dyke J, Goldblatt M, Duan R, Kinch MS, Li WB.

Virology. 2009 May 10;387(2):473-81. doi: 10.1016/j.virol.2009.02.046. Epub 2009 Mar 27.

2.

Identification of novel host-oriented targets for Human Immunodeficiency Virus type 1 using Random Homozygous Gene Perturbation.

Mao H, Chen H, Fesseha Z, Chang S, Ung-Medoff H, Van Dyke J, Kohli M, Li WB, Goldblatt M, Kinch MS.

Virol J. 2009 Sep 29;6:154. doi: 10.1186/1743-422X-6-154.

3.

Identification of annexin A13 as a regulator of chemotherapy resistance using random homozygous gene perturbation.

Reiske H, Sui B, Ung-Medoff H, Donahue R, Li WB, Goldblatt M, Li L, Kinch MS.

Anal Quant Cytol Histol. 2010 Apr;32(2):61-9.

PMID:
20701074
4.

Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbation.

Li WB, Zhu J, Hart B, Sui B, Weng K, Chang S, Geiger R, Torremorell M, Mileham A, Gladney C, Mellancamp MA, Li L, Yunus A, Goldblatt M, Kinch MS.

Am J Transl Res. 2009 Apr 12;1(3):259-66.

5.

FGI-104: a broad-spectrum small molecule inhibitor of viral infection.

Kinch MS, Yunus AS, Lear C, Mao H, Chen H, Fesseha Z, Luo G, Nelson EA, Li L, Huang Z, Murray M, Ellis WY, Hensley L, Christopher-Hennings J, Olinger GG, Goldblatt M.

Am J Transl Res. 2009 Jan 5;1(1):87-98.

6.

Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.

Lee SM, Yen HL.

Antiviral Res. 2012 Dec;96(3):391-404. doi: 10.1016/j.antiviral.2012.09.013. Epub 2012 Sep 26. Review.

PMID:
23022351
7.

Genome-wide RNAi screen for viral replication in mammalian cell culture.

Prusty BK, Karlas A, Meyer TF, Rudel T.

Methods Mol Biol. 2011;721:383-95. doi: 10.1007/978-1-61779-037-9_24.

PMID:
21431699
8.

A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.

Hsu SF, Su WC, Jeng KS, Lai MM.

J Virol. 2015 Apr;89(7):3671-82. doi: 10.1128/JVI.03610-14. Epub 2015 Jan 14.

9.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

10.

Screening methods for influenza antiviral drug discovery.

Atkins C, Evans CW, White EL, Noah JW.

Expert Opin Drug Discov. 2012 May;7(5):429-38. doi: 10.1517/17460441.2012.674510. Epub 2012 Mar 22. Review.

PMID:
22435452
11.

Influenza A immunomics and public health omics: the dynamic pathway interplay in host response to H1N1 infection.

Dimitrakopoulou K, Dimitrakopoulos GN, Wilk E, Tsimpouris C, Sgarbas KN, Schughart K, Bezerianos A.

OMICS. 2014 Mar;18(3):167-83. doi: 10.1089/omi.2013.0062. Epub 2014 Feb 10.

PMID:
24512282
12.

Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice.

Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, Rowe S, Finkelstein D, Neale G, Lu L, Williams RW, Webby RJ.

J Virol. 2009 Oct;83(20):10417-26. doi: 10.1128/JVI.00514-09. Epub 2009 Aug 12.

13.

Proteomic analysis at the subcellular level for host targets against influenza A virus (H1N1).

Zhao H, Yang J, Li K, Ding X, Lin R, Ma Y, Liu J, Zhong Z, Qian X, Bo X, Zhou Z, Wang S.

Antiviral Res. 2013 Dec;100(3):673-87. doi: 10.1016/j.antiviral.2013.10.005. Epub 2013 Oct 22.

PMID:
24161511
14.

Gene expression signature-based screening identifies new broadly effective influenza a antivirals.

Josset L, Textoris J, Loriod B, Ferraris O, Moules V, Lina B, N'guyen C, Diaz JJ, Rosa-Calatrava M.

PLoS One. 2010 Oct 4;5(10). pii: e13169. doi: 10.1371/journal.pone.0013169.

15.

Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein.

Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, Beer M, Wolff T.

J Virol. 2010 Oct;84(20):10708-18. doi: 10.1128/JVI.00610-10. Epub 2010 Aug 4.

16.

The landscape of host transcriptional response programs commonly perturbed by bacterial pathogens: towards host-oriented broad-spectrum drug targets.

Kidane YH, Lawrence C, Murali TM.

PLoS One. 2013;8(3):e58553. doi: 10.1371/journal.pone.0058553. Epub 2013 Mar 13.

17.

Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants.

Metzgar D, Myers CA, Russell KL, Faix D, Blair PJ, Brown J, Vo S, Swayne DE, Thomas C, Stenger DA, Lin B, Malanoski AP, Wang Z, Blaney KM, Long NC, Schnur JM, Saad MD, Borsuk LA, Lichanska AM, Lorence MC, Weslowski B, Schafer KO, Tibbetts C.

PLoS One. 2010 Feb 3;5(2):e8995. doi: 10.1371/journal.pone.0008995.

18.

A Drosophila model for genetic analysis of influenza viral/host interactions.

Adamson AL, Chohan K, Swenson J, LaJeunesse D.

Genetics. 2011 Oct;189(2):495-506. doi: 10.1534/genetics.111.132290. Epub 2011 Jul 20.

19.

Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy.

Sgarbanti R, Nencioni L, Amatore D, Coluccio P, Fraternale A, Sale P, Mammola CL, Carpino G, Gaudio E, Magnani M, Ciriolo MR, Garaci E, Palamara AT.

Antioxid Redox Signal. 2011 Aug 1;15(3):593-606. doi: 10.1089/ars.2010.3512. Epub 2011 May 19.

PMID:
21366409
20.

Supplemental Content

Support Center